1. Home
  2. GRWG vs XBIT Comparison

GRWG vs XBIT Comparison

Compare GRWG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

N/A

Current Price

$1.12

Market Cap

89.2M

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.34

Market Cap

73.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRWG
XBIT
Founded
2008
2005
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.2M
73.2M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
GRWG
XBIT
Price
$1.12
$2.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
349.3K
34.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,365,479.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
142.51
N/A
52 Week Low
$0.83
$2.09
52 Week High
$2.40
$3.62

Technical Indicators

Market Signals
Indicator
GRWG
XBIT
Relative Strength Index (RSI) 31.78 43.99
Support Level $0.95 $2.32
Resistance Level $1.21 $2.69
Average True Range (ATR) 0.07 0.08
MACD 0.00 -0.01
Stochastic Oscillator 8.33 22.22

Price Performance

Historical Comparison
GRWG
XBIT

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: